CGMP becomes a drug target

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 3, 2012, Pages 243-252

  Schlossmann, Jens ^a   Schinner, Elisabeth ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

cGMP; cGMP dependent protein kinase; Guanylate cyclases; Guanylyl cyclases; Natriuretic peptides; Pulmonary hypertension; sGC activator; sGC stimulator

Indexed keywords

ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CENDERITIDE; CINACIGUAT; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; ENALAPRIL; GUANYLATE CYCLASE; LCZ 696; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NESIRITIDE; NITRIC OXIDE; PROTEIN TYROSINE PHOSPHATASE SHP 1; REACTIVE NITROGEN SPECIES; RIOCIGUAT; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG; CELL RECEPTOR; SOLUBLE GUANYLYL CYCLASE;

ACHONDROPLASIA; BINDING SITE; BONE DYSPLASIA; CARDIOMYOPATHY; CELL FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; DRUG TARGETING; DUCHENNE MUSCULAR DYSTROPHY; GENE LOCUS; GENETIC ASSOCIATION; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INTRAVASCULAR HEMOLYSIS; KIDNEY FIBROSIS; KNOCKOUT MOUSE; LOSS OF FUNCTION MUTATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN PROCESSING; PULMONARY HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SRC HOMOLOGY DOMAIN; TRANSGENIC MOUSE; ANIMAL; CARDIOVASCULAR DISEASES; DRUG DESIGN; DRUG EFFECTS; HYPERTENSION, PULMONARY; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; CYCLIC GMP; DRUG DESIGN; GUANYLATE CYCLASE; HUMANS; HYPERTENSION, PULMONARY; MOLECULAR TARGETED THERAPY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84862857097     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0730-6     Document Type: Review

References (61)

1. Adamo CM, Dai D-F, Percival JM, Minami E, Willis MS, Patrucco E, Froehner SC, Beavo JA (2010) Sildenafil reverses cardiac dys-function in the mdx mouse model of Duchenne muscular dystro-phy. Proc Natl Acad Sci 107:19079-19083
2. Afzal F, Qvigstad E, Aronsen JM, Moltzau LR, Sjaastad I, Skomedal T, Osnes JB, Levy FO (2011) Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle. Naunyn Schmiedebergs Arch Pharmacol 384:543-553
3. Ahmed KA, Sawa T, Akaike T (2011) Protein cysteine S-guanylation and electrophilic signal transduction by endogenous nitro-nucleotides. Amino Acids 41:123-130
4. Alverdi V, Mazon H, Versluis C, Hemrika W, Esposito G, van den Heuvel R, Scholten A, Heck AJ (2008) cGMP-binding prepares PKG for substrate binding by disclosing the C-terminal domain. J Mol Biol 375:1380-1393
5. Beste KY, Burhenne H, Kaever V, Stasch JP, Seifert R (2012) Nucle-otidyl cyclase activity of soluble guanylyl cyclase alpha(1)beta (1). Biochemistry 51:194-204
6. Boerrigter G, Costello-Boerrigter LC, Burnett JC Jr (2009) Natriuretic peptides in the diagnosis and management ofchronic heart failure. Heart Fail Clin 5:501-514
7. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C, Roviezzo F, Brancaleone V, Cirino G (2010) Hydro-gen sulfide is an endogenous inhibitor of phosphodiesterase ac-tivity. Arterioscler Thromb Vasc Biol 30:1998-2004
8. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schroder E, Browning DD, Eaton P (2007) Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317:1393-1397 (Pubitemid 47417480)
9. Burley DS, Ferdinandy P, Baxter GF (2007) Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152:855-869 (Pubitemid 350100488)
10. Casteel DE, Smith-Nguyen EV, Sankaran B, Roh SH, Pilz RB, Kim C (2010) A crystal structure of the cyclic GMP-dependent protein kinase I{beta} dimerization/docking domain reveals molecular details ofisoform-specific anchoring. J Biol Chem 285:32684-32688
11. Chen J, Crossland RF, Noorani MM, Marrelli SP (2009) Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelax-ation. Am J Physiol Heart Circ Physiol 297:H417-H424
12. Derbyshire ER, Marletta MA (2009) Biochemistry of soluble guany-late cyclase. Handb Exp Pharmacol 17-31
13. Desch M, Schinner E, Kees F, Hofmann F, Seifert R, Schlossmann J (2010) Cyclic cytidine 3',5'-monophosphate (cCMP) signals via cGMP kinase I. FEBS Lett 584:3979-3984
14. Donadee C, Raat NJ, Kanias T, Tejero J, Lee JS, Kelley EE, Zhao X, Liu C, Reynolds H, Azarov I et al (2011) Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 124:465-476
15. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang SJ et al (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478:103-109
16. Ehrlich PJ, Lanyon LE (2002) Mechanical strain and bone cell func-tion: areview. Osteoporos Int 13:688-700 (Pubitemid 35000996)
17. Evgenov OV, Zou L, Zhang M, Mino-Kenudson M, Mark EJ, Buys ES, Li Y, Feng Y, Raher MJ, Stasch JP et al (2011) Stimulation of soluble guanylate cyclase attenuates bleomycin-induced pulmo-nary fibrosis in mice. Am J Respir Crit Care Med 183:A2715
18. Finsterer J, Stollberger C (2003) The heart in human dystrophinopa-thies. Cardiology 99:1-19
19. Ghofrani HA, Hoeper MM, Halank M, Meyer FJ, Staehler G, Behr J, Ewert R, Weimann G, Grimminger F (2010) Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. Eur Respir J 36:792-799
20. Ghofrani HA, Staehler G, Gruenig E, Halank M, Mitrovic V, Unger S, Mueck W, Frey R, Behr J (2011) The effect of the soluble guanylate cyclase stimulator riocigiuat on hemodynamics in patients with pulmonary hypertension due to chronic obstructive pulmonary disease. Am J Crit Care Med 183:A6127
21. Gottle M, Dove S, Kees F, Schlossmann J, Geduhn J, Konig B, Shen Y Tang WJ, Kaever V, Seifert R (2010) Cytidylyl and uridylyl cyclase activity ofBacillus anthracis edema factor and Bordetella pertussis CyaA. Biochemistry 49:5494-5503
22. Groneberg D, Konig P, Koesling D, Friebe A (2011) Nitric oxide-sensitive guanylyl cyclase is dispensable for nitrergic signaling and gut motility in mouse intestinal smooth muscle. Gastroenter-ology 140:1608-1617
23. Guazzi M, Vicenzi M, Arena R, Guazzi MD (2011) Pulmonary hyper-tension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 124:164-174
24. Haas B, Mayer P, Jennissen K, Scholz D, Berriel Diaz M, Bloch W, Herzig S, Fassler R, Pfeifer A (2009) Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis. Sci Signal 2:ra78
25. Haghikia A, Mergia E, Friebe A, Eysel UT, Koesling D, Mittmann T (2007) Long-term potentiation in the visual cortex requires both nitric oxide receptor guanylyl cyclases. J Neurosci 27:818-823 (Pubitemid 46174500)
26. Hedlund P, Aszodi A, Pfeifer A, Alm P, Hofmann F, Ahmad M, Fassler R, Andersson KE (2000) Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice. Proc Natl Acad Sci USA 97:2349-2354 (Pubitemid 30134072)
27. Hoeper M, Halank M, Wilkens H, Günther A, Weimann G, Gebert I, Leuchte H, Behr J (2010) Riociguat for patients with pulmonary hypertension associated with interstitial lung disease. Am J Respir Crit Care Med 181:A5262
28. Hofmann F, Bernhard D, Lukowski R, Weinmeister P (2009) cGMP regulated protein kinases (cGK). Handb Exp Pharma-col 137-162
29. Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X, Tay WT, Chen CH, Zhang Y Yamamoto K et al (2011) Meta-analysis of genome-wide association studies identifies common variants as-sociated with blood pressure variation in East Asians. Nat Genet 43:531-538
30. Klaiber M, Dankworth B, Kruse M, Hartmann M, Nikolaev VO, Yang RB, Volker K, Gassner B, Oberwinkler H, Feil R et al (2011) A cardiac pathway of cyclic GMP-independent signaling of guanylyl cyclase A, the receptor for atrial natriuretic peptide. Proc Natl Acad SciUSA 108:18500-18505
31. Knighton DR, Zheng JH, Ten Eyck LF, Ashford VA, Xuong NH, Taylor SS, Sowadski JM (1991) Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253:407-414 (Pubitemid 21917165)
32. Kuhn M (2009) Function and dysfunction of mammalian membrane guanylyl cyclase receptors: lessons from genetic mouse models and implications for human diseases. Handb Exp Pharmacol 191:47-69
33. Kwan HY, Huang Y, Yao X (2004) Regulation of canonical transient receptor potential isoform 3 (TRPC3) channel by protein kinase G. Proc Natl Acad Sci USA 101:2625-2630 (Pubitemid 38269361)
34. LandgrafW, Hofmann F, Pelton JT, Huggins JP (1990) Effects ofcyclic GMP on the secondary structure of cyclic GMP dependent protein kinase and analysis of the enzyme's amino-terminal domain by far-ultraviolet circular dichroism. Biochemistry 29:9921-9928 (Pubitemid 20348528)
35. Lukowski R, Rybalkin SD, Loga F, Leiss V, Beavo JA, Hofmann F (2010) Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes. Proc Natl Acad Sci USA 107:5646-5651
36. Martin F, Baskaran P, Ma X, Dunten PW, Schaefer M, Stasch JP, Beuve A, van den Akker F (2010) Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase. J Biol Chem 285:22651-22657
37. McKie PM, Sangaralingham SJ, Burnett JC Jr (2010) CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease. Curr Heart Fail Rep 7:93-99
38. Mergia E, Koesling D, Friebe A (2009) Genetic mouse models of the NO receptor 'soluble' guanylyl cyclases. Handb Exp Pharmacol 33-46
39. Neitz A, Mergia E, Eysel UT, Koesling D, Mittmann T (2011) Presynaptic nitric oxide/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus. Eur J Neurosci 33:1611-1621
40. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, Bis JC, Marciante K, Rivadeneira F, Noseworthy PA et al (2009a) Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 41:399-406
41. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, Guiducci C, Kathiresan S, Benjamin EJ, Struck J et al (2009b) Association of common variants in NPPA and NPPB with circulat-ing natriuretic peptides and blood pressure. Nat Genet 41:348-353
42. Nishikimi T, Kuwahara K, Nakao K (2011) Current biochemistry, molecular biology, and clinical relevance ofnatriuretic peptides. J Cardiol 57:131-140
43. Osborne BW, Wu J, McFarland CJ, Nickl CK, Sankaran B, Casteel DE, Woods VL Jr, Kornev AP, Taylor SS, Dostmann WR (2011) Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication. Structure 19:1317-1327
44. Prysyazhna O, Rudyk O, Eaton P (2012) Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med. doi:10.1038/nm.2603
45. Rangaswami H, Marathe N, Zhuang S, Chen Y, Yeh J-C, Frangos JA, Boss GR, Pilz RB (2009) Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction. J Biol Chem 284: 14796-14808
46. Rangaswami H, Schwappacher R, Marathe N, Zhuang S, Casteel DE, Haas B, Chen Y, Pfeifer A, Kato H, Shattil S et al (2010) Cyclic GMP and protein kinase G control a Src-containing mechano-some in osteoblasts. Sci Signal 3:ra91
47. Reinecke D, Burhenne H, Sandner P, Kaever V, Seifert R (2011) Human cyclic nucleotide phosphodiesterases possess a much broader substrate- specificity than previously appreciated. FEBS Letters
48. Ruilope LM, Dukat A, Bohm M, Lacourciere Y, Gong J, Lefkowitz MP (2010) Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. Lancet375:1255-1266
49. Sayed N, Kim DD, Fioramonti X, Iwahashi T, Duran WN, Beuve A (2008) Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ Res 103:606-614
50. Singh AK, Spießberger B, Zheng W, Xiao F, Lukowski R, Wegener JW, Weinmeister P, Saur D, Klein S, Schemann M, Krueger D, Seidler U, Hofmann F (2012) Neuronal cGMP kinase I is essential for stimulation of duodenal bicarbonate secretion by luminal acid. Faseb J. doi:10.1096/fj.11-200394
51. Stasch JP, Pacher P, Evgenov OV (2011) Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation 123:2263-2273
52. Su Y Dostmann WR, Herberg FW, Durick K, Xuong NH, Ten Eyck L, Taylor SS, Varughese KI (1995) Regulatory subunit of protein kinase A: structure of deletion mutant with cAMP binding domains. Science 269:807-813
53. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gero D, Szoleczky P, Chang T, Zhou Z, Wu L et al (2011) Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci USA 108:13829-13834
54. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA (2005) Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11:214-222 (Pubitemid 40321358)
55. Taub PR, Gabbai-Saldate P, Maisel A (2010) Biomarkers of heart failure. Congest Heart Fail 16(Suppl 1):S19-S24
56. Taylor SS, Kornev AP (2011) Protein kinases: evolution ofdynamic regulatory proteins. Trends Biochem Sci 36:65-77
57. Vanhoutte PM (2009) How we learned to say NO. Arterioscler Thromb Vasc Biol 29:1156-1160
58. Werner K, Schwede F, Genieser HG, Geiger J, Butt E (2011) Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides. Naunyn Schmiedebergs Arch Pharmacol 384:169-176
59. Yasoda A, Nakao K (2010) Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias. Endocr J 57:659-666
60. Yuasa K, Matsuda T, Tsuji A (2011) Functional regulation of transient receptor potential canonical 7 by cGMP-dependent protein kinase Ialpha. Cell Signal 23:1179-1187
61. Zhao J, Trewhella J, Corbin J, Francis S, Mitchell R, Brushia R, Walsh D (1997) Progressive cyclic nucleotide-induced conformational changes in the cGMP-dependent protein kinase studied by small angle X-ray scattering in solution. J Biol Chem 272:31929-31936 (Pubitemid 28013347)